肝细胞癌射频消融后即刻评估消融边缘与指数肿瘤的影像学:多排CT与MRI对比
前瞻性比较33例患者42个肝细胞癌射频消融后即刻多排CT与MRI评估消融边缘(AM)和指数肿瘤的能力,MRI在视觉区分AM与指数肿瘤方面显著优于MDCT(81% vs 9.5%,p<0.001),且MRI AM-plus者局部肿瘤进展累积发生率显著更低(p=0.007),非增强MRI有限序列亦优于常规MDCT方案。
要点
- MRI对射频消融后AM与指数肿瘤的视觉区分能力显著优于MDCT(81% vs 9.5%,p<0.001)。
- MRI上AM-plus者局部肿瘤进展累积发生率显著低于非AM-plus者(p=0.007)。
- 非增强MRI有限序列(仅T1WI和T2WI)评估AM亦优于常规MDCT方案。
核心结论
- MRI在肝细胞癌射频消融后即刻区分消融边缘与指数肿瘤方面优于MDCT,非增强MRI亦优于常规MDCT方案;增强MRI对AM和指数肿瘤的评估无附加价值。
研究设计与样本
- 前瞻性研究,纳入33例连续患者共42个肝细胞癌,由两名放射科医师独立评估MDCT和MRI图像,AM状态分为AM-plus、AM-zero、AM-minus,随访分析局部肿瘤进展累积率采用Kaplan-Meier法和Cox比例风险模型。
关键影像表现/征象
- MDCT上42个消融区中仅4个(9.5%)可视觉区分AM与指数肿瘤,MRI上34个(81%)可区分(p<0.001)。
- MDCT图像上38个分类为AM-plus、4个为AM-zero;MRI图像上32个为AM-plus、9个为AM-zero、1个为AM-minus。
- MRI上AM-plus者的局部肿瘤进展累积发生率显著更低(p=0.007)。
诊断标准与关键数值
- AM-plus:消融边缘完全包绕肿瘤。
- AM-zero:消融边缘部分不连续,但无肿瘤突出。
- AM-minus:消融边缘部分不连续,伴有肿瘤突出。
临床应用与阅片要点
- 射频消融后即刻可采用MRI(含非增强有限序列)评估消融边缘与指数肿瘤,其视觉区分能力优于常规MDCT。
- 增强MRI对消融边缘和指数肿瘤的评估未显示附加价值。
- MRI上AM-plus与更低的局部肿瘤进展累积发生率相关(p=0.007)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To prospectively compare multidetector-row CT (MDCT) and MR imaging (MRI) in the assessment of the ablative margin (AM) and index tumor immediately after radiofrequency (RF) ablation for hepatocellular carcinoma (HCC) and assess whether non-contrast MRI with limited sequences (T1- and T2-weighted imaging only) was superior to a conventional MDCT protocol.
METHODS: A total of 33 consecutive patients with 42 HCCs were included in this study. Both MDCT and MR images were independently reviewed by two radiologists regarding the ability to visually discriminate between the AM and index tumor, and the AM status within ablation zones. The AM status was classified as AM-plus (AM completely surrounding the tumor), AM-zero (AM was partly discontinuous, without protrusion of the tumor), and AM-minus (AM was partly discontinuous, with protrusion of the tumor). During the follow-up period, the cumulative local tumor progression rates were analyzed using the Kaplan-Meier method and Cox proportional hazards model. To determine the added value of contrast-enhanced MR images, both reviewers separately evaluated the two sets (unenhanced and enhanced) of MR images.
RESULTS: Visual discrimination between the AM and index tumor was possible in four (9.5%) and 34 (81%) of the 42 ablation zones using MDCT and MRI, respectively (p < 0.001). Thirty-eight and four cases were classified as AM-plus and AM-zero on MDCT images, respectively, whereas the ablation zones were categorized as AM-plus (n = 32), AM-zero (n = 9), and AM-minus (n = 1) when examining the MR images. The cumulative incidence of local tumor progression was significantly lower in cases with AM-plus on MRI (p = 0.007). Contrast-enhanced MRI had no added value for the assessment of the AM and index tumor.
CONCLUSION: MRI was superior to MDCT for the differential assessment of the AM and index tumor immediately after RF ablation for HCC. Non-contrast MRI was also superior to the conventional MDCT protocol.
引用
- Kim SM, Shin SS, Lee BC, et al. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging. Abdom Radiol (NY). 2017. PMID: 28409202. doi:10.1007/s00261-017-1146-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。